Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centers.
Sibert NT, Wesselmann S, Breidenbach C, Blohmer J, Brückner B, Gebauer G, Dos Santos Guilherme M, Hartkopf A, Lindner C, Peschel S, Rieger L, Schad F, Strecker P, Ferencz J, Dieng S, Inwald EC, Kowalski C, Ortmann O.
Sibert NT, et al. Among authors: strecker p.
J Cancer Res Clin Oncol. 2022 Mar;148(3):719-726. doi: 10.1007/s00432-021-03651-1. Epub 2021 Apr 29.
J Cancer Res Clin Oncol. 2022.
PMID: 33914125